Reported 6 months ago
Penny stocks, often polarizing for investors due to the potential high returns and risks involved, are gaining attention. TipRanks highlights two penny stocks with 'Strong Buy' consensus ratings. One stock, Vigil Neuroscience, operates in the biotech sector with a drug candidate showing promise in Phase 2 trials for treating neurological diseases. The other stock, SCPharmaceuticals, focuses on heart failure treatments and has a recently FDA-approved product. Analysts see significant upside potential of up to 750% for these stocks, emphasizing the importance of following professional recommendations in navigating the penny stock market.
Source: YAHOO